5.050
+1,00%
2026-10-19
Fundamental Analysis
46 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +161.6% | -1427.7% | 1 / 3 | +17.0% | -8.87 pp | +37.44 pp | -3.9% | 0.91 | — | 142 | +17,0% | 12,7 | +136,7% | — | 2.55 | — |
| Pts | 12 | 0 | 4 | 8 | 0 | 12 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 5.050 (close price on 2026-10-19)EPS (TTM): −391,7
Financial charts
1.Revenue & growth
VND bn142Q2/26
1.Revenue & growth
VND bn142Q2/26
2.Profit & growth
VND bn9,13Q2/26
3.Profit mix (Penman)
VND bn-27,6Q2/26
4.Margins & cost structure
%20.9%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn130Q2/26
7.Asset structure
VND bn1.919Q2/26
8.Funding & debt health
VND bn · times1.919Q2/26
9.Revenue backlog
VND bn1,27Q2/26
10.Valuation
times · %-8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %119Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-2222%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26